Helping projects
change the future
APPLY NOW

Team

 
Timur Avdeenko

Timur Avdeenko

Managing partner, Investment committee member
Ph.D., member of the board of directors at Le Click, Dr Botkin.
Previously, chairman of the management board at MDM Bank, president & chairman of the board of directors at EMAliance, vice president at Alfa Bank. 25 years of experience in finance and investment projects in mining, clinical medicine, retail.

Timur Avdeenko

Managing partner, Investment committee member
Ph.D., member of the board of directors at Le Click, Dr Botkin.
Previously, chairman of the management board at MDM Bank, president & chairman of the board of directors at EMAliance, vice president at Alfa Bank. 25 years of experience in finance and investment projects in mining, clinical medicine, retail.
Timur Avdeenko
 
Dmitry Sharov

Dmitry Sharov

Managing partner, Investment committee member
With almost 20 years of experience in clinical trials industry, Dmitry has been successfully running the OCT Group, having grown it to the size of 200 employees. Within OCT Group, Dmitry holds the position of president at OCT Clinical Trials, a leading CRO in Eastern Europe, and Data MATRIX, an eClinical software provider. Within the companies, Dmitry is responsible for the establishment of the corporate vision and business strategy development.

Dmitry Sharov

Managing partner, Investment committee member
With almost 20 years of experience in clinical trials industry, Dmitry has been successfully running the OCT Group, having grown it to the size of 200 employees. Within OCT Group, Dmitry holds the position of president at OCT Clinical Trials, a leading CRO in Eastern Europe, and Data MATRIX, an eClinical software provider. Within the companies, Dmitry is responsible for the establishment of the corporate vision and business strategy development.
Dmitry Sharov
 
Anton Lavrentev

Anton Lavrentev

CEO
Anton has extensive experience in corporate law, investments and intellectual property. He provides legal advice in deal-making process and supports Fund’s operations. Anton developed his expertise while working for more than 7 years on M&A projects as an associate in law firm and as an in-house counsel. He received his bachelor’s and master’s degrees in Law from the Higher School of Economics.

Anton Lavrentev

CEO
Anton has extensive experience in corporate law, investments and intellectual property. He provides legal advice in deal-making process and supports Fund’s operations. Anton developed his expertise while working for more than 7 years on M&A projects as an associate in law firm and as an in-house counsel. He received his bachelor’s and master’s degrees in Law from the Higher School of Economics.
Anton Lavrentev
 
Elizaveta Rozhdestvenskaya

Elizaveta Rozhdestvenskaya

COO
Elizaveta is a specialist with more than eight years of experience in venture capital financing of biopharmaceutical projects. She graduated from the Mechanics and Mathematics Faculty and the Biology Faculty with a degree in Genetics of Lomonosov Moscow State University. The main direction of her scientific activities was the research in the field of mathematical modeling of gene interactions. Elizaveta is an author of a number of scientific papers and a speaker at international conferences.

Elizaveta Rozhdestvenskaya

COO
Elizaveta is a specialist with more than eight years of experience in venture capital financing of biopharmaceutical projects. She graduated from the Mechanics and Mathematics Faculty and the Biology Faculty with a degree in Genetics of Lomonosov Moscow State University. The main direction of her scientific activities was the research in the field of mathematical modeling of gene interactions. Elizaveta is an author of a number of scientific papers and a speaker at international conferences.
Elizaveta Rozhdestvenskaya
 
Evgeny Shevchenko

Evgeny Shevchenko

Project Manager
Responsible for coordination and control of research activities of the Fund's portfolio companies. Evgeny graduated from Moscow State University with a specialization in Biochemistry and received a postgraduate degree in the faculty of fundamental medicine. He holds a Ph.D degree in Biology. Moreover, Evgeny has experience in the organization and coordination of scientific and research programs, as well as in project management for development and preclinical studies of pharmaceuticals. Evgeny also has experience in domestic and foreign scientific grants and government contracts.

Evgeny Shevchenko

Project Manager
Responsible for coordination and control of research activities of the Fund's portfolio companies. Evgeny graduated from Moscow State University with a specialization in Biochemistry and received a postgraduate degree in the faculty of fundamental medicine. He holds a Ph.D degree in Biology. Moreover, Evgeny has experience in the organization and coordination of scientific and research programs, as well as in project management for development and preclinical studies of pharmaceuticals. Evgeny also has experience in domestic and foreign scientific grants and government contracts.
Evgeny Shevchenko
 
NADEZHDA KARTASHOVA

NADEZHDA KARTASHOVA

Adviser
Nadezhda graduated from the Pharmacy Faculty of the St. Petersburg State Chemical-Pharmaceutical Academy and holds a PhD degree in Pharmaceutical Sciences. Nadezhda has attended various international internships on the organization of pharmaceutical production in accordance with GMP standards and studied biotechnology in the Dublin City University, Ireland for a few months.

NADEZHDA KARTASHOVA

Adviser
Nadezhda graduated from the Pharmacy Faculty of the St. Petersburg State Chemical-Pharmaceutical Academy and holds a PhD degree in Pharmaceutical Sciences. Nadezhda has attended various international internships on the organization of pharmaceutical production in accordance with GMP standards and studied biotechnology in the Dublin City University, Ireland for a few months.
NADEZHDA KARTASHOVA
 
Sofya Yartseva

Sofya Yartseva

Consultant
Sofya is responsible for analysis of pre-investment research data from project companies. She graduated from the department of biological and medical physics of Moscow Institute of Physics and Technology, took part in the International Exchange Program with Ecole Polytechnique (Paris) and had an internship at the department of molecular genetics, genomics and microbiology of Strasbourg University. Sofya has over 3 years’ experience in the field of biotechnology and drug discovery and is a co-author of several scientific articles.

Sofya Yartseva

Consultant
Sofya is responsible for analysis of pre-investment research data from project companies. She graduated from the department of biological and medical physics of Moscow Institute of Physics and Technology, took part in the International Exchange Program with Ecole Polytechnique (Paris) and had an internship at the department of molecular genetics, genomics and microbiology of Strasbourg University. Sofya has over 3 years’ experience in the field of biotechnology and drug discovery and is a co-author of several scientific articles.
Sofya Yartseva
 

Expert Council

 
Catherine Boule

Catherine Boule

Advisory Board Member
Managing Partner at CapDecisif Management in charge of the Healthcare portfolio. She is involved in the overall management of the firm, including fundraising activities and investor relations. MSc in Molecular Biology, Catherine started out her career as molecular biology researcher at the University Pierre and Marie Curie (Paris). Adding to this a business degree, she joined Ile de France Innovation, an incubator, where she assisted several Biotech and MedTech companies in their development. Catherine represents CapDecisif Management at the board of several portfolio companies such as Acticor Biotech, Eyevensys, Tricares, Vitamfero and WatchFrog. Catherine was an investor and board member of Echosens, DBV Technologies, Erytech Pharma, Nanobiotix, Voluntis.

Catherine Boule

Advisory Board Member
Managing Partner at CapDecisif Management in charge of the Healthcare portfolio. She is involved in the overall management of the firm, including fundraising activities and investor relations. MSc in Molecular Biology, Catherine started out her career as molecular biology researcher at the University Pierre and Marie Curie (Paris). Adding to this a business degree, she joined Ile de France Innovation, an incubator, where she assisted several Biotech and MedTech companies in their development. Catherine represents CapDecisif Management at the board of several portfolio companies such as Acticor Biotech, Eyevensys, Tricares, Vitamfero and WatchFrog. Catherine was an investor and board member of Echosens, DBV Technologies, Erytech Pharma, Nanobiotix, Voluntis.
Catherine Boule
 
John Edward Butler-Ransohoff, Dr

John Edward Butler-Ransohoff, Dr

Advisory Board Member
VP External Innovation & Alliances at Bayer Pharmaceuticals Division at Bayer AG. John studied Chemistry at Heidelberg University and obtained a PhD at the Max Planck Institute for Medical Research (1986). He was a research fellow at Rockefeller University, New York (1986-1988). He has over 31 years of experience in pharmaceutical R&D in a variety of roles including Medicinal Chemistry, Project Manager and leading several corporate and divisional staff functions (R&D Coordination and Business and Project Strategies Pharmaceuticals). John represents Bayer in the Investment Committee of the High-Technology Gründer-Fonds (HTGF), Europe biggest seed fund. He is a member of the advisory board of several European research consortia and is a Visiting Professor at the Institute for Infection and Immunity, St George's, University of London.

John Edward Butler-Ransohoff, Dr

Advisory Board Member
VP External Innovation & Alliances at Bayer Pharmaceuticals Division at Bayer AG. John studied Chemistry at Heidelberg University and obtained a PhD at the Max Planck Institute for Medical Research (1986). He was a research fellow at Rockefeller University, New York (1986-1988). He has over 31 years of experience in pharmaceutical R&D in a variety of roles including Medicinal Chemistry, Project Manager and leading several corporate and divisional staff functions (R&D Coordination and Business and Project Strategies Pharmaceuticals). John represents Bayer in the Investment Committee of the High-Technology Gründer-Fonds (HTGF), Europe biggest seed fund. He is a member of the advisory board of several European research consortia and is a Visiting Professor at the Institute for Infection and Immunity, St George's, University of London.
John Edward Butler-Ransohoff, Dr
 
Vadim Tarasov

Vadim Tarasov

Advisory Board Member
Director of the I.M. Sechenov University Translational Medicine and Biotechnology Institute. Vadim is a graduate of the I.M. Sechenov Moscow Medical Academy Pharmacy Department.  Head of the Pharmaceutics Department at the Institute of Pharmacy (I.M. Sechenov First Moscow State Medical University). PhD in Pharmaceutics. Area of scientific interest - discovering innovative medicine for oncological and neurodegenerative diseases along with contributing to the stimulating scientific and educative environment. Contributed over 30 publications to Scopus, h-index 6, co-authored 12 patents.

Vadim Tarasov

Advisory Board Member
Director of the I.M. Sechenov University Translational Medicine and Biotechnology Institute. Vadim is a graduate of the I.M. Sechenov Moscow Medical Academy Pharmacy Department.  Head of the Pharmaceutics Department at the Institute of Pharmacy (I.M. Sechenov First Moscow State Medical University). PhD in Pharmaceutics. Area of scientific interest - discovering innovative medicine for oncological and neurodegenerative diseases along with contributing to the stimulating scientific and educative environment. Contributed over 30 publications to Scopus, h-index 6, co-authored 12 patents.
Vadim Tarasov